The World Health Organization has updated its essential medicines list to include key diabetes treatments, improving access to innovative care. Advancements also feature AI-paired devices and smarter insulin systems for better management. These tools aim to enhance monitoring and delay onset in at-risk groups.
Innovations Highlighted
Updates include closed-loop artificial pancreas systems, inhaled insulin, and advanced continuous glucose monitoring.
Global Benefits
These developments could reduce complications and improve quality of life for diabetes patients.